Remove Doctors Remove Gene Remove Genomics Remove Pharma Companies
article thumbnail

Gene editing: beyond the hype

pharmaphorum

Genome editing is an exciting but still nascent field, and companies in the area face as many obstacles as they do opportunities. Sangamo CEO Sandy Macrae told us how his company is being cautious about the hype and finding ways to be financially viable in an emerging space. Zinc fingers.

article thumbnail

AI tissue analysis enables rapid discovery of drug candidates

pharmaphorum

The potential of the area has motivated an increasing number of companies to emerge in the space, with a greater number of collaborations occurring between these AI-specialists and big pharma companies. Patient focus.

Drugs 96
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

WHO Honors the Legacy and Contribution of Henrietta Lacks

XTalks

The cell line, called HeLa, laid the foundation for many groundbreaking discoveries, including vaccines for the human papilloma virus (HPV) and polio; drugs for HIV and cancers; gene mapping; IVF treatment; and more recently, for crucial COVID-19 research. Fittingly, it was also used to develop the vaccine against cervical cancer.

article thumbnail

A history of the pharmaceutical industry

pharmaphorum

Another military man in the drugs business was Edward Robinson Squibb, who as a naval doctor during the Mexican-American war of 1846–1848 threw the drugs he was supplied with overboard due to their low quality. He was a pioneer of new methods in the industry, being one of the first to focus on R&D as well as manufacturing.

Medicine 145